Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Moderna Is Shooting Higher Today

TheMotleyFool

0 0

Coronavirus stock Moderna (NASDAQ: MRNA) was up by nearly 8% in mid-afternoon trading on Thursday. Two pieces of news about the company's coronavirus vaccine seem to be supporting this rise.

The first is Moderna's announcement that dosing of participants has begun in a phase 1/2 clinical trial for mRNA-1273 in Japan. This study, which is being led by Japanese pharmaceutical company Takeda (NYSE: TAK), seeks to enroll 200 people aged 20 and older.

Image source: Getty Images.

Source Fool.com

Like: 0

MRNA

Share